Paolo Martelletti
Sapienza Università di Roma
H-index: 60
Europe-Italy
Top articles of Paolo Martelletti
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
Real-world effectiveness of fremanezumab in patients with migraine switching from another mAb targeting the CGRP pathway | Dental and Medical Problems | Marta Waliszewska-Prosół Paolo Martelletti | 2024 |
Targeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine prevention | Lanfranco Pellesi Messoud Ashina Paolo Martelletti | 2024/2/12 | |
Unmet needs in the acute treatment of migraine | Advances in Therapy | Enrico Bentivegna Silvia Galastri Dilara Onan Paolo Martelletti | 2024/1 |
Potential benefits and possible risks of multitherapy CGRP-targeted in migraine | Keiko Ihara Tsubasa Takizawa Narumi Watanabe Jin Nakahara Paolo Martelletti | 2024/2/8 | |
The Preoperative Assessment of Frailty in the Setting of Transcatheter Aortic Valve Implantation (TAVI): A Systematic Review | Antonio Martocchia Laura Vero Denise Pezzella Silvia Sciaulino Lorenzo Caracciolo | 2024/12 | |
Mechanosensitive receptors in migraine: a systematic review | Adriana Della Pietra Laura Gómez Dabó Petr Mikulenka Christian Espinoza-Vinces Doga Vuralli | 2024/1/15 | |
A proposal of actions for stakeholders and policy makers to address the global burden of headache disorders by 2030: why is this important for global health? | Alberto Raggi Matilde Leonardi Paolo Martelletti | 2024/4/20 | |
The World Health Organization Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders and the headache revolution: from headache burden to a global action … | Matilde Leonardi Paolo Martelletti Rami Burstein Arianna Fornari Licia Grazzi | 2024/1/4 | |
Placebo responses vary by route of administration in migraine prevention trials. What does this mean? | Christina I Deligianni Paolo Martelletti Dimos D Mitsikostas | 2024/2/26 | |
Potential benefits and possible risks of CGRP-targeted multitherapy in migraine | Keiko Ihara Tsubasa Takizawa Narumi Watanabe Jin Nakahara Paolo Martelletti | 2024 | |
Patient Sex in Prescribing CGRP Receptor Antagonists for Migraine | JAMA neurology | Michel Lanteri-Minet Shuu-Jiun Wang Paolo Martelletti | 2024/2/26 |
Antiseizure medications as migraine preventatives: a call for action for a teratogenic and neurodevelopmental risk removal | William Wells-Gatnik Paolo Martelletti | 2023/9/2 | |
Gepants in the acute management of migraine | William David Wells-Gatnik Paolo Martelletti | 2023/11 | |
Long-term course of COVID-19 vaccination-related headache: A prospective multicenter follow-up study | International Headache Congress (IHC) | Arife Cimen Atalar Ayşe Nur Özdağ Acarlı Betül Baykan Hayrunnisa Bolay Mustafa Ertaş | 2023 |
COVID-19 and SARS-CoV-2 vaccines: a cameo role for headache | International Journal of Environmental Research and Public Health | Paolo Martelletti | 2023/2/22 |
What Is the Best Methodology for Headache or Migraine Research? | Cristina Gaglianone Enrico Bentivegna Paolo Martelletti | 2023/3/31 | |
The use of clinical scales and PROMs in headache disorders and migraine, summarizing their dissemination and operationalization | Pınar Yalinay Dikmen Aynur Ozge Paolo Martelletti | 2023/5/13 | |
Emerging experimental drugs in clinical trials for migraine: observations and key talking points | William David Wells-Gatnik Tiffany Yazmin Wences Chirino Fatma Nur Onan Dilara Onan Paolo Martelletti | 2023/8/3 | |
The measurement of the left ventricle ejection fraction by a bedside FoCUS examination | Internal and Emergency Medicine | Antonio Martocchia Cinzia Piccoli Michele Fortunato Notarangelo Daniela Sergi Beata Ostrowska | 2023/11 |
The efficacy of physical therapy and rehabilitation approaches in chronic migraine: a systematic review and meta-analysis | Dilara Onan Esme Ekizoğlu Halime Arıkan Bahar Taşdelen Aynur Özge | 2023 |